体外膜氧合用于创伤后急性呼吸窘迫综合征:系统评价与荟萃分析
该系统评价与荟萃分析检索PubMed、Embase和Cochrane Central(从建库至2025年3月),纳入4项观察性队列研究、共1526例成人创伤性ARDS患者(ECMO 179例,传统机械通气1347例)。ECMO组死亡率显著降低(OR 0.29,95%CI 0.14-0.62,p=0.001),静脉-静脉ECMO亚组获益更明显(OR 0.19,95%CI 0.07-0.53,p=0.002)。ECMO组ICU住院时间显著延长(标准化均数差1.54,95%CI 0.97-2.12,p<0.01),总并发症、呼吸机相关性肺炎和住院时间无显著差异。作者认为,鉴于观察性数据的局限、选择标准不一和异质性,这些发现仍是假设生成性的,需要前瞻性创伤特异性研究确认获益并指导最佳使用。
要点
- 成人创伤性ARDS患者中,ECMO与传统机械通气相比死亡率更低(OR 0.29,95%CI 0.14-0.62,p=0.001),静脉-静脉ECMO亚组OR 0.19(95%CI 0.07-0.53)。
- ECMO组ICU住院时间显著延长(标准化均数差1.54,95%CI 0.97-2.12,p<0.01),总并发症、呼吸机相关性肺炎及住院时间无显著差异。
- 证据来自4项观察性队列研究、1526例患者(ECMO 179例,传统机械通气1347例),作者认为结果属假设生成性。
- 作者指出观察性数据存在局限、选择标准不一和异质性,需要前瞻性创伤特异性研究确认获益并指导最佳使用。
适用人群与场景
- 成人创伤患者合并急性呼吸窘迫综合征,接受体外膜氧合(静脉-静脉或静脉-动脉)与传统机械通气比较。
研究设计与关键结果
- 研究类型为系统评价与荟萃分析,纳入4项观察性队列研究,共1526例成人创伤性ARDS患者(ECMO 179例,传统机械通气1347例)。
- 主要终点死亡率:ECMO组显著低于传统机械通气组(OR 0.29,95%CI 0.14-0.62,p=0.001)。
- 静脉-静脉ECMO亚组死亡率获益更明显(OR 0.19,95%CI 0.07-0.53,p=0.002)。
- ECMO组ICU住院时间显著延长(标准化均数差1.54,95%CI 0.97-2.12,p<0.01)。
- 总并发症、呼吸机相关性肺炎和住院时间无显著差异。
证据类型、等级与局限
- 证据类型为系统评价与荟萃分析,证据等级为Level IV。
- 局限:观察性数据存在局限、选择标准不一和异质性;这些发现仍是假设生成性的,需要前瞻性创伤特异性研究确认获益并指导最佳使用。
对床旁实践的改变
- 作者认为,ECMO似乎可降低成人创伤性ARDS的死亡率,但与ICU住院时间延长和大量资源需求相关。
- 作者指出,鉴于观察性数据的局限、选择标准不一和异质性,这些发现仍是假设生成性的,需要前瞻性创伤特异性研究确认获益并指导最佳使用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is increasingly used in severe acute respiratory distress syndrome (ARDS) when conventional mechanical ventilation (CMV) fails. While large trials such as Conventional ventilatory Support vs Extracorporeal membrane oxygenation for Severe Adult Respiratory failure and Extracorporeal membrane Oxygenation for Severe Acute Respiratory Distress Syndrome have demonstrated ECMO's benefit in general ARDS, trauma-induced ARDS remains underrepresented. This systematic review and meta-analysis aimed to assess ECMO's efficacy and safety compared with CMV in adult trauma patients with ARDS.
METHODS: We systematically searched PubMed, Embase, and Cochrane Central from inception to March 2025 following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies included adult trauma patients with ARDS treated with ECMO (venovenous or venoarterial) versus CMV. The primary outcome was mortality; secondary outcomes included complications, ventilator-associated pneumonia, duration of mechanical ventilation, hospital length of stay (LOS), and intensive care unit (ICU) LOS. Risk of bias was assessed using the Risk of Bias in Nonrandomized Studies of Interventions tool.
RESULTS: Four observational cohort studies involving 1,526 patients (ECMO, 179; CMV, 1,347) were included. Extracorporeal membrane oxygenation was associated with significantly lower mortality (odds ratio, 0.29; 95% confidence interval [CI], 0.14-0.62; p = 0.001), with an even greater benefit in the venovenous ECMO subgroup (odds ratio, 0.19; 95% CI, 0.07-0.53; p = 0.002). Extracorporeal membrane oxygenation recipients had significantly longer ICU stays (standardized mean difference, 1.54; 95% CI, 0.97-2.12; p < 0.01), but no significant differences were found in total complications, ventilator-associated pneumonia, or hospital LOS.
CONCLUSION: Extracorporeal membrane oxygenation appears to reduce mortality in adult trauma-induced ARDS but is associated with prolonged ICU stay and substantial resource demands. Given the limitations of observational data, variable selection criteria, and heterogeneity across studies, these findings remain hypothesis generating. Prospective trauma-specific studies are needed to confirm the benefit and guide optimal use.
LEVEL OF EVIDENCE: Systematic Review and Meta-analysis; Level IV.
参考来源
- Akbarpoor F, Mokhtar J, Madera D, et al. Use of extracorporeal membrane oxygenation in traumatic injuries with acute respiratory distress syndrome: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2025. PMID: 41405389. doi:10.1097/TA.0000000000004826
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。